A Randomized, Double-Blind, Placebo-Controlled, Clinical Trial to Assess the Efficacy and Safety of 12 Weeks of Satiereal(R) Supplementation on Food Cravings and Preferences, Body Composition, Satiety and Appetite Regulatory Hormones, and Clinical Safety Markers in Overweight/Obese Individuals

Not Applicable

Completed

• Conditions: snacking behavior; obesity; Diet and Nutrition - Obesity

• Registration Number: ACTRN12612000092897
• Lead Sponsor: Matthew Cooke

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2012-01-18
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: Female
• Target Recruitment: 72

Inclusion Criteria

Healthy females with a body mass index (BMI) greater than 25 kg/m2 and less than 35 kg/m2.

Exclusion Criteria

Exclusion criteria include recent pregnancy, history of cancer, diabetes (fasting blood glucose greater than 126mg/dL or hemoglobin A1c test greater than 6.5%), pathologic eating disorder, anxiety or depression, abnormal liver or kidney function, concomitant medication or psychotropic drugs or appetite suppressants, gastric surgery, or the use of any dietary supplement that might interfere with the results of the study.

Study & Design

• Study Type: Interventional
• Study Design: Not specified